Breast Cancer Treatment: How CDK4/6 Inhibitors Work (monarchE & NATALEE Trials)

69 Visioni

  • Grazie! Condividilo con i tuoi amici!

    Non hai gradito questo video. Grazie per il feedback!

admin
Published
Article: https://oncologytube.com/breast-cancer-cdk46-inhibitors-explained/
Learn how CDK4/6 inhibitors like abemaciclib and ribociclib improve breast cancer treatment for HR+/HER2- early-stage patients by addressing hormone therapy resistance. Dr. Austin Williams from Fox Chase Cancer Center discusses their mechanism, results from the monarchE and NATALEE trials, and future applications for patients and clinicians.

Timestamps:
0:00 - Introduction to CDK4/6 Inhibitors
0:06 - How CDK4/6 Inhibitors Address Hormone Therapy Resistance
0:40 - monarchE Trial: Abemaciclib Results
1:05 - NATALEE Trial: Ribociclib Results
1:29 - Comparing monarchE and NATALEE Trials
2:40 - Why Palbociclib Failed in Early Breast Cancer
3:50 - Future Applications of CDK4/6 Inhibitors
4:37 - Guidance for Surgeons

Like, Share, Subscribe! Hit the bell for updates on cancer research and clinical topics.

About OncologyTube.com:
OncologyTube.com is a free video-sharing platform dedicated to oncology professionals, offering cancer research updates through videos, audio, PowerPoint presentations, and more. Visit OncologyTube.com for a detailed web post on this and many other cancer topics and oncology insights.

Follow OncologyTube:
eNewsletter: https://oncologytube.com/newsletter/
Twitter: https://twitter.com/OncologyTube
LinkedIn: https://www.linkedin.com/company/oncologytube-com
Facebook: https://www.facebook.com/OncologyTube
Instagram: https://www.instagram.com/oncologytube
YouTube: https://www.youtube.com/c/OncologyTube

Connect with Us:
Share your thoughts in the comments! Join the discussion.
Categoria
Oncology
Commenta per primo questo video.

Prossimo